Table 2.
Recanalization problem | APC solution |
---|---|
No reflow phenomenon due to rethrombosis, migration of emboli, secondary thrombosis of downstream arteries, or microcirculatory occlusion | Antithrombotic activity |
Reperfusion injury, hemorrhagic transformation, or cerebral edema, | Vasculoprotective effects on BBB integrity |
Neurotoxicity | Neuroprotection |
Recanalization occurs too late | Neurogenesis and Angiogenesis |
The potential explanations for poor clinical outcome despite reopening of occluded vessels and the beneficial properties of APC that redress each of these pitfalls are summarized.